Home › Funds › ADAR1 Capital Management, LLC › ZLAB

ADAR1 Capital Management, LLC position in ZLAB

Zai Lab Ltd · Health Care

ADAR1 Capital Management, LLC reported holding 3,369,034 shares of ZLAB (Zai Lab Ltd) in its Q2 2026 13F filing — a position valued at US$64.0M, representing 3.55% of its reported portfolio and ranking #4 among its reported holdings. ADAR1 Capital Management, LLC has disclosed ZLAB holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)3.37M sh
Reported value held$64.01M
Portfolio Weight3.55%
First reportedQ4 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ADAR1 Capital Management, LLC's ZLAB position evolved

ADAR1 Capital Management, LLC first disclosed a stake in ZLAB in Q4 2023 at 20,000 shares (US$547K). The position peaked in Q2 2026 at 3,369,034 shares, worth US$64.0M. Across 11 filings, ADAR1 Capital Management, LLC increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 3,369,034 shares valued at US$64.0M — an increase of 1,943,667 shares quarter over quarter.. Notable position changes include a 2320% increase in Q3 2024 (shares rose 8% over the following quarter), a 96% increase in Q4 2024 (shares rose 38% over the following quarter), a 136% increase in Q2 2026 (shares rose 39% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 20.00K $546.60K New
Q1 2024 22.00K $352.44K Add
Q2 2024 22.00K $381.26K Hold
Q3 2024 532.45K $12.85M Add
Q4 2024 1.05M $27.39M Add
Q1 2025 940.86K $34.00M Reduce
Q2 2025 850.44K $29.74M Reduce
Q3 2025 868.78K $29.44M Add
Q4 2025 1.25M $21.99M Add
Q1 2026 1.43M $26.81M Add
Q2 2026 3.37M $64.01M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZLAB and 13F data

ZLAB (Zai Lab Ltd) is a Health Care company. 14 other funds we track also report a position in ZLAB — the largest reported positions include RTW INVESTMENTS, LP (US$124.9M), TCG Crossover Management, LLC (US$116.6M), RA CAPITAL MANAGEMENT, L.P. (US$109.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZLAB

All ZLAB fund holders →

FAQ

How long has ADAR1 Capital Management, LLC held ZLAB?

ADAR1 Capital Management, LLC has disclosed ZLAB holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is ADAR1 Capital Management, LLC's current position in ZLAB?

As of Q2 2026, ADAR1 Capital Management, LLC holds 3.37M shares of ZLAB (Zai Lab Ltd), valued at $64.01M, representing 3.55% of its reported portfolio and ranking #4.

Has ADAR1 Capital Management, LLC been buying or selling ZLAB?

In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC increased its position in ZLAB. The position peaked in Q2 2026 at 3.37M shares.

Which other funds hold ZLAB?

Other major institutional holders of ZLAB include RTW INVESTMENTS, LP, TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., among 14 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.